Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
      1
23
4
5678
910111213
14
15
16
17
1819202122
23242526272829
30      
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009

  • Immediately following the first 3 infusions, the combined craving score decreased by 54% in the treatment group, compared to a 35%  decrease in the placebo group.
  • Positive urine drug screens were statistically significantly lower for the OnTrak group overall. On any given day, the OnTrak subjects had a lower proportion of positive urine drug screens.
  • Consecutive clean urines represent a longer abstinence period. Two consecutive clean urines in the four week study occurred in 42% of the treated subjects and 27% of the placebo subjects, which was statistically significant.
  • The reduction in craving was highly correlated with predicting use within this study. This is consistent with literature on the importance of cravings in driving use.

OnTrak- treated subjects had a lower percent of methamphetamine use by self-report. 





| |

 

 
  Tags
 
marijuana opiod-based methadone muscle relaxant behavioral health care services medical and behavioral costs trauma addiction treatment recovery Opioid Medications oxycodone data mining hospital chronic pain substance use disorder drug addicts meth contract mental health prescriptions suboxone stimulants Health Care Utilization substance dependence costs CIWA anxiety Opioid Prescribing health reform communication sober ADHD gabapentin painkillers reduction in use overdose placebo alcohol dependence hydrocodone pain medication reducing craving Catasys ADD craving score UnitedHealthcare over-the-counter substances drug treatment alcohol flumazenil high-utilizing sobriety Harold Urschel drug overdose SD health insurance Opioid Treatment depression screening double-blind depression stress randomized opioid heroin addict OnTrak SD members vivitrol cocaine treatment diabetes pain killers health plan codeine craving recovery network substance dependence health insurance predictive modeling smoking reduction in craving primary care mental illness facebook health insurance opioid antagonist vicodin behavioral healthcare fentanyl opiod abuse physician- patient relations drug abuse treatment naloxone alcoholism medical costs narcotic dependence issues nicotine bipolar disorder opioid-drug interactions behavioral health care Research Across America Co Occurring Disorders alcohol treatment PTSD relapse prometa drug addiction cocaine Raymond Anton cigarettes drinking identification opioid overdose drug use Journal of Psychopharmacology care coaching alcohol drinking percocet emergency room psychosocial ER OxyContin placebo-controlled behavioral health morphine methamphetamine dependence methamphetamine buprenorphine medical relapse prevention stratified opiates post-traumatic stress disorder urine drug screen pain pills sugar hospitalizations withdrawal binge drinking behavioral healthcare services substance dependence opioid abuse addiction social network
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414